Trials / Completed
CompletedNCT04729257
Norms Expansion and Validation for IntelliSpace Cognition
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 508 (actual)
- Sponsor
- Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
This study aims to expand the normative dataset for Philips IntelliSpace Cognition to include ages 18-49 and 80+ and aims to validate two new digital tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Philips IntelliSpace Cognition (ISC). | Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices. |
| DIAGNOSTIC_TEST | Paper-Pencil Tests. | The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice. |
Timeline
- Start date
- 2021-03-08
- Primary completion
- 2021-07-02
- Completion
- 2021-07-02
- First posted
- 2021-01-28
- Last updated
- 2021-10-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04729257. Inclusion in this directory is not an endorsement.